Dimensional Fund Advisors
PHIO icon

Dimensional Fund Advisors’s Phio Pharmaceuticals PHIO Stock Holding History

Dimensional Fund Advisors’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-222
Closed -$54K – 3524
2021
Q2 		$54K Sell
222
-100
-31% -$24.6K ﹤0.01% 3436
2021
Q1 		$93K Buy
322
+89
+38% +$29.6K ﹤0.01% 3357
2020
Q4 		$68K Buy
+233
New +$58.9K ﹤0.01% 3298
2015
Q1 		– Hold
0
– – – 3380
2014
Q4 		– Hold
0
– – – 3523
2014
Q3 		– Hold
0
– – – 3559
2014
Q2 		– Hold
0
– – – 3600
2014
Q1 		– Hold
0
– – – 3598

Other funds holding PHIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors's PHIO Position: Q3 2021 in Review

Dimensional Fund Advisors sold out of Phio Pharmaceuticals (PHIO) in Q3 2021, closing a stake of 222 shares — an estimated $54K sold.

Dimensional Fund Advisors first reported a position in PHIO in Q4 2020 and held it in 3 quarters. The position peaked at $93K in Q1 2021. 15 funds tracked by Wall St. Rank hold PHIO as of Q3 2021.

  • Dimensional Fund Advisors reported no remaining Phio Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 222 Phio Pharmaceuticals shares in Q3 2021, an estimated $54K.
  • Dimensional Fund Advisors first reported a position in Phio Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Dimensional Fund Advisors's Phio Pharmaceuticals position peaked at $93K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2021.

Based on Dimensional Fund Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.